FDA Drug recall D-0467-2024
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95),…
- FDA Drug
- Class III
- ongoing
- Published 2024-05-01
On 2024-05-01 the FDA classified a Class III recall of Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95),… by Second Tokushima Factory Otsuka Pharmaceutical, citing cross Contamination with Other Products.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0467-2024 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2024-04-09 |
| Published | 2024-05-01 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Second Tokushima Factory Otsuka Pharmaceutical |
| Distribution | US |
Product
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
Reason
Cross Contamination with Other Products
Identifiers
| ndc | 59148-006-13 |
|---|---|
| ndc | 59148-006-92 |
| ndc | 59148-007-13 |
| ndc | 59148-007-35 |
| ndc | 59148-007-94 |
| ndc | 59148-008-13 |
| ndc | 59148-008-35 |
| ndc | 59148-008-95 |
| ndc | 59148-009-13 |
| ndc | 59148-009-35 |
| ndc | 59148-009-95 |
| ndc | 59148-010-13 |
| ndc | 59148-010-35 |
| ndc | 59148-011-13 |
| ndc | 59148-011-35 |
| code_info | Lot #: a) ALS00422A, Exp 04/30/2025; ALS00523A, Exp 11/30/2025; b) 1K77YUD1H1A, Exp 11/30/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0467-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.